A gemcitabine intermediate compound

CN115504906BActive Publication Date: 2026-08-28SHANDONG NEW TIME PHARMA CO LTD
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
CN202110701151.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-06-22
Publication Date
2026-08-28
Estimated Expiration
2041-06-22

AI Technical Summary

Technical Problem

[0021]上述文献中,3-氰基4-甲氧基-2(1H)-吡啶酮的制备方法除文献二氢嘧啶脱氢酶抑制剂吉美拉西的合成.《华西药学杂志》,2008,23(3),252-254中将2-(1-甲氧基亚乙基)丙二腈单独分离制备外,其它文献均以丙二腈为起始物料,“一锅法”制得1,1-二氰基-2-甲氧基-4-(N,N-二甲基氨基)-1,3-丁二烯后再环化制备,但由于环化过程会生成胺臭味的沸点仅为9℃的二甲胺有毒气体,对环境危害较大;并且相关二甲胺气体进一步会与所用溶剂醋酸成盐析出,使得相关产品纯度较低,需要进一步水洗打浆除盐提纯,操作较为繁琐

Benefits of technology

[0039]1.提供了一种新的吉美嘧啶中间体化合物,同时提供了利用该该新中间体简便高效的制备吉美嘧啶关键中间体3-氰基-4-甲氧基-2(1H)-吡啶酮的方法,整个合成方法操作简便,反应收率高;

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure QLYQS_1
    Figure QLYQS_1
  • Figure QLYQS_2
    Figure QLYQS_2
  • Figure BDA0003127168900000011
    Figure BDA0003127168900000011
Patent Text Reader

Abstract

The application belongs to the technical field of medicine synthesis, and particularly relates to a gemigim intermediate compound. The gemigim new intermediate compound is obtained by reacting 2-(1-methoxy ethylene) malonitrile and triethyl orthoformate as starting materials. Meanwhile, the application provides a method for preparing a key intermediate 3-cyano-4-methoxy-2(1H)-pyridinone of the gemigim by using the new intermediate. The synthesis method of the new intermediate is simple, the synthesis route of the gemigim prepared by using the new intermediate is short, the yield is high, the reaction condition is mild, the process is stable, and the method is suitable for mass industrial production.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A process for the preparation of a gemiglimine intermediate compound, characterized by, The preparation method includes the following steps: at room temperature, 12.21g of 2-(1-methoxyethylidene)malononitrile and 17.78g of triethyl orthoformate are added to 80mL of 1,4-dioxane and the reaction is carried out at 80-85℃. After the reaction is detected to be complete, the reaction solution is concentrated to dryness under reduced pressure to obtain I-1. At room temperature, 8.91 g of intermediate I-1 was added to 60 mL of 80% acetic acid solution, and the reaction was carried out under controlled reflux. After the reaction was completed, the reaction solution was cooled to 25°C to induce crystallization, and light yellow needle-like crystals precipitated out. The crystals were filtered, and the resulting filter cake was washed with water and dried to obtain the target product I. The synthesis route is as follows: ; 。

Citation Information

Patent Citations

  • Process for production of 5-chloro-2,4-dihydroxypyridine

    CN101107230A

  • Synthetic method for gimeracil

    CN106316934A

  • Preparation method of gimeracil intermediate

    CN112110854A

  • Process for production of 5-chloro-2,4-dihydroxypyridine

    EP1842847A1

  • Alpha,beta-unsaturated ketoester derivative

    JP1993039241A